Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma

BACKGROUND: Adrenocortical carcinoma (ACC) is an aggressive cancer with a 5 year survival rate of 20–30 %. Various factors have been implicated in the pathogenesis of ACC including dysregulation of the G2/M transition and aberrant activity of p53 and MDM2. Polo-like kinase 1 (PLK-1) negatively modul...

Descripción completa

Detalles Bibliográficos
Autores principales: Bussey, Kimberly J., Bapat, Aditi, Linnehan, Claire, Wandoloski, Melissa, Dastrup, Erica, Rogers, Erik, Gonzales, Paul, Demeure, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709336/
https://www.ncbi.nlm.nih.gov/pubmed/26754547
http://dx.doi.org/10.1186/s40169-015-0080-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709336/
https://www.ncbi.nlm.nih.gov/pubmed/26754547
http://dx.doi.org/10.1186/s40169-015-0080-3

Ejemplares similares